These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11079151)

  • 1. Therapeutic use of radiolabelled peptides.
    Krenning EP; de Jong M
    Ann Oncol; 2000; 11 Suppl 3():267-71. PubMed ID: 11079151
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiolabelled peptides--promises and pitfalls.
    Mather SJ
    Nucl Med Commun; 2000 Jun; 21(6):507-9. PubMed ID: 10894558
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiolabelled peptides in diagnosis and therapy: an introduction.
    AL-Nahhas A; Fanti S
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S1-3. PubMed ID: 22388632
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiolabelled regulatory peptides for imaging and therapy.
    Breeman WA; Kwekkeboom DJ; de Blois E; de Jong M; Visser TJ; Krenning EP
    Anticancer Agents Med Chem; 2007 May; 7(3):345-57. PubMed ID: 17504160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
    de Jong M; Kwekkeboom D; Valkema R; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):463-9. PubMed ID: 12569416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide radiopharmaceuticals for diagnosis and therapy.
    Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
    Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: facts and myths about the Scylla and Charybdis.
    Behr TM; Béhé M; Kluge G; Gotthardt M; Schipper ML; Gratz S; Arnold R; Becker W; Goldenberg DM
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):277-9. PubMed ID: 11926391
    [No Abstract]   [Full Text] [Related]  

  • 10. From the magic bullet to an effective therapy: the peptide experience.
    Mansi L
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1393-8. PubMed ID: 15351914
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide radiopharmaceuticals in diagnosis and therapy of cancer and inflammation/infection. Proceedings of the 16th IRIST (International Research Group on Immunoscintigraphy and Therapy) Congress. May 8-10, 2003.
    Cancer Biother Radiopharm; 2004 Feb; 19(1):55-134. PubMed ID: 15068611
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
    Giblin MF; Veerendra B; Smith CJ
    In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides for tumour therapy and diagnosis: current status and future directions.
    Zaccaro L; Del Gatto A; Pedone C; Saviano M
    Curr Med Chem; 2009; 16(7):780-95. PubMed ID: 19275595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
    Sosabowsky J; Melendez-Alafort L; Mather S
    Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
    Koopmans KP; Glaudemans AW
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoradiotherapy in cancer treatment--basic concepts and future trends.
    Zoller F; Eisenhut M; Haberkorn U; Mier W
    Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
    Okarvi SM
    Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-based radiopharmaceuticals for targeted tumor therapy.
    Dong C; Liu Z; Wang F
    Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.
    Banerjee S; Pillai MR; Knapp FF
    Chem Rev; 2015 Apr; 115(8):2934-74. PubMed ID: 25865818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.